Breaking News

Samsung Biologics to Participate in Frontier 1.5D Initiative

Will develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the challenges associated with climate change.

Author Image

By: Charlie Sternberg

Associate Editor

Samsung Biologics, a contract development and manufacturing organization, has signed an MOU to participate in the Frontier 1.5D initiative to develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the ongoing challenges associated with global climate change.   The Frontier 1.5D project is a global collaborative effort to limit temperature rise to 1.5°C above pre-industrial levels, and local business leaders have joined forces with the British Embassy, Ewha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters